Boston Scientific Cross-Appeals Stent Patent Ruling
Weeks after Johnson & Johnson Inc. appealed a federal court's ruling that four of its patents for drug-eluting stents are invalid, Boston Scientific Corp. has notified the court that it will...To view the full article, register now.
Already a subscriber? Click here to view full article